Skip to content

Effects of a Patient-Centered Medication Self-Management Support Program for Cancer Patients: a Mixed-Method Study

Effects of a Patient-Centered Medication Self-Management Support Program for Cancer Patients: a Mixed-Method Study - Effects of a Medication Self-Management Support Program for Cancer Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016597
Enrollment
200
Registered
2015-02-27
Start date
2015-03-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

We developed the Patient-Centred Medication Self-Management Support Programme consisting of three elements: information-giving using teach back, patient preference, and follow-up by nurse under the co

Sponsors

Keio University, Faculty of Nursing and Medical Care
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: They are:(1) 20-89 years of age, (2) patients with metastatic breast cancer, (3) able to complete to the questionnaire in Japanese, (4) newly prescribed oral chemotherapy or target therapy medication, (5) able to manage medication without any assistance, or (6) having prognosis of more than three months determined by the primary physician.

Exclusion criteria

Exclusion criteria: They (1) have cognitive impairment or mental disorders, (2) have brain metastasis, (3) receive infusion therapy, and (4) are participants in another study.

Design outcomes

Primary

MeasureTime frame
Adherence to medication(:medication procession ratio (MPR)

Secondary

MeasureTime frame
:Self-efficacy, Quality of life, Psychological distress, Symptoms severity and interference, Patient satisfaction, Emergency department visits, and hospital admissions.

Countries

Japan

Contacts

Public ContactKaori Yagasaki

Keio University Faculty of Nursing and Medical Care

yagasaki@sfc.keio.ac.jp03-5363-2157

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026